Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Healthcare Industry News Innocan Pharma reports placebo-controlled clinical evidence supporting long-acting LPT-CBD for canine osteoarthritis pain Innocan Pharma Corporation publishes placebo-controlled clinical data supporting long-acting LPT-CBD for osteoarthritis pain. Find out what it means for non-opioid pain markets. bySrinathFebruary 10, 2026